Peregrine Pharmaceuticals reported $50K in Interest Income for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Income Change
BioCryst Pharmaceuticals BCRX:US USD 2.7M 944K
Intrexon XON:US USD 2K 54K
Karyopharm Therapeutics KPTI:US USD 1.33M 676K
MannKind MNKD:US USD 957K 294K
NewLink Genetics NLNK:US USD 503K 211K
Xencor XNCR:US USD 2.07M 689K